• All
  • Cloud
    • Solutions
    • Virtualization
  • Data
    • Analytics
    • Big Data
    • Customer Data Platform
  • Digital
    • Digital Marketing
    • Social Media Marketing
  • Finance
    • Cost Management
    • Risk & Compliance
  • Human Resources
    • HR Solutions
    • Talent Management
  • IT Infra
    • App Management Solutions
    • Best Practices
    • Datacenter Solutions
    • Infra Solutions
    • Networking
    • Storage
    • Unified Communication
  • Mobility
  • Sales & Marketing
    • Customer Relationship Management
    • Sales Enablement
  • Security
  • Tech
    • Artificial Intelligence
    • Augmented Reality
    • Blockchain
    • Chatbots
    • Internet of Things
    • Machine Learning
    • Virtual Reality
The Rising Usage of GLP-1 Medications for Obesity and What It Will Cost You

The Rising Usage of GLP-1 Medications for Obesity and What It Will Cost You

Published by: Research Desk Released: Sep 28, 2022

Understanding the inevitable increase in obesity medication utilization Obesity is the largest category of chronic disease and a major driver of healthcare costs. Over 40% of Americans are living with obesity, and this number forecasted to be closer to 50% by 2030—making it apparent that this growing healthcare crisis requires immediate action.

Despite the gravity of the obesity epidemic, legacy obesity treatments have either failed to produce effective results, or have failed to be widely adopted. GLP-1s were originally created for diabetes, but are now indicated for obesity treatment. Given their efficacy and the size of the addressable market, GLP-1 medications are set to become the next blockbuster pharma category, with a projection of $70B in sales by 2030. Download the eBook to learn about the inevitable increase in obesity medication utilization, and how you can control the associated costs for your organization

Welcome Dear

Thank you for your interest and your registration with Teradata. Please confirm your e-mail address to complete your registration by clicking here

Yes, confirm my

By confirming this, you give Teradata your consent to send you information on our data analytics products and services or invitations to events and webinars by e-mail from time to time. You can revoke this consent at any time by clicking on the unsubscribe link at the bottom of each of our e-mails. We assure you that we treat your contact details with the utmost care. Detailed information on how we store and use your personal data or how you can exercise your rights regarding your personal data can be found in the global Teradata Privacy Policy.